Private menopause care
Menopause and perimenopause treatment
Private, assessment-led menopause care for women experiencing hot flushes, sleep changes, anxiety, brain fog, vaginal or urinary symptoms, low libido, early menopause or uncertainty about HRT and non-hormonal options.
- CQC registered Regulated and inspected
- 4.8 / 5 From 3,500+ reviews
- Clinician-led Personalised care
A national menopause and perimenopause care hub
This page explains WHC’s private menopause service: how symptoms are assessed, what treatment categories may be discussed, what affects suitability, how prescriptions and reviews are managed, and how to reach the right consultation pathway.
It is the national service hub rather than a city landing page. Women looking for a specific clinic can use our clinic directory, while vaginal dryness and clinically specific GSM concerns have their own condition-led assessment pages.
This national page owns
Menopause assessment and treatment planning
Use this page when you want to understand perimenopause, menopause or postmenopause, private consultation routes, HRT and non-hormonal options, monitoring and ongoing clinical care.
See how assessment worksFor local appointments
Choose the appropriate clinic route
Clinic pages provide verified location-specific information. This national hub does not adopt city keywords or imply that every consultation type is available at every site.
Explore WHC clinicsFor focused intimate symptoms
Use the Dryness or GSM pathway when appropriate
Vaginal dryness is a symptom-led pathway. Vaginal atrophy/GSM is the clinically specific vulval, vaginal and urinary condition pathway. Menopause remains the broader hormonal-care hub.
Transition stage
Perimenopause
Perimenopause is the transition towards menopause. Periods may become irregular, heavier, lighter or less predictable, although symptoms can begin while cycles still appear regular.
Clinical definition
Menopause and postmenopause
Natural menopause is reached after 12 consecutive months without a period when no other cause explains the change. Postmenopause is the life stage that follows.
Needs tailored planning
Early menopause, POI and surgical menopause
Menopause before 45, premature ovarian insufficiency before 40, or sudden menopause after ovarian surgery can affect fertility, bone health, cardiovascular health and emotional wellbeing.
Menopause symptoms can affect the whole person
Symptoms vary in type, intensity and duration. They may overlap with thyroid problems, anaemia, sleep disorders, medication effects, mood conditions, infection, pelvic-floor problems and other medical causes.
Hot flushes and night sweats
Vasomotor symptoms can interrupt sleep, work, exercise and confidence. Their frequency and severity are important when discussing treatment.
Sleep, fatigue and brain fog
Poor sleep can amplify fatigue, memory problems and reduced concentration. A review also considers other causes rather than assuming every symptom is hormonal.
Mood, anxiety and irritability
Hormonal change can contribute to anxiety, low mood or emotional volatility, but severe depression, crisis symptoms or immediate risk need urgent mental-health support.
Periods, libido and sexual wellbeing
Cycle changes, reduced desire, arousal changes or painful intimacy may be part of the picture. These concerns need respectful, cause-led discussion rather than assumptions.
Joints, body composition and long-term health
Joint aches, muscle changes and altered fat distribution may occur. Bone, cardiovascular and metabolic health are considered according to age, history and risk.
Vaginal, vulval and urinary symptoms
Dryness, burning, painful intimacy, urgency or recurrent UTI-like symptoms may reflect GSM and may need a dedicated vaginal or urinary assessment pathway.
Do not assume it is “just menopause”
Some symptoms need prompt medical assessment
Seek prompt clinical review for postmenopausal or unexplained bleeding, new pelvic pain, a breast or vulval change, persistent urinary symptoms, suspected infection, sudden neurological symptoms, or symptoms suggesting another medical condition.
Severe low mood, suicidal thoughts or an immediate mental-health crisis require urgent support through emergency services, NHS 111, your GP or an appropriate crisis service rather than a routine menopause booking.
A history of hormone-sensitive cancer, blood clots, liver disease, unexplained bleeding or complex medical treatment does not automatically exclude all support, but it changes the assessment, treatment choices and referral pathway.
Who may benefit?
A consultation can help when symptoms, choices or risks feel unclear
You do not need to arrive knowing whether you want HRT. The purpose is to understand the clinical picture and make an informed decision.
Symptoms are affecting daily life
Sleep, work, mood, cognition, relationships, exercise or confidence are being affected and you want a joined-up review.
You want to understand HRT and non-hormonal options
You have questions about suitability, route, benefits, risks, local treatment, alternatives or monitoring and want a personalised discussion.
You may have early, surgical or complex menopause
Early menopause, POI, cancer treatment, ovarian surgery or a complex medical history may need more detailed risk assessment and specialist coordination.
You need an intimate-health or contraception handoff
GSM, vaginal dryness, recurrent urinary symptoms, painful sex, Mirena or contraception questions may need a linked but distinct pathway.
What happens during private menopause care?
The route is designed to move from an appropriate first conversation to a full assessment, shared decision and planned review—without treating medication as automatic.
Choose the right first consultation
A nurse consultation is available from £50. A doctor telephone consultation is £150 where a medical route is preferred or advised.
The first step explains the pathway; it is not the same as a full menopause assessment.
Book a full menopause consultation
The full initial consultation is £175 nurse-led or £250 doctor-led. The appropriate practitioner and format are confirmed before booking.
Face-to-face assessment may be advised when examination or complex review is needed.
History, diagnosis context and goals
Your clinician reviews symptoms, cycle history, medical and family history, medicines, contraception, previous treatment, risk factors and priorities.
Diagnosis is often clinical in women over 45; tests are used only where indicated.
Shared decision and review plan
Options, alternatives, benefits, risks, uncertainties, prescriptions and follow-up are explained before a plan is agreed.
You can choose advice only, take time to decide or request another opinion.
What assessment covers
One governed clinical sequence
Symptoms and impact
Pattern, severity, cycle relationship, sleep, mood, work, intimacy and quality of life.
Medical safety
Personal and family history, bleeding, cancer, clot, liver, migraine and cardiovascular factors.
Tests only when useful
Testing may help in younger women, unusual presentations, differential diagnosis or monitored treatments.
Preferences and goals
Hormonal or non-hormonal preference, symptom priorities, contraception and acceptable monitoring.
Patient control
Treatment is not automatic
A consultation can end with education, monitoring, self-care, a prescription, further testing, an intimate-health pathway or referral. The outcome depends on the assessment—not on a pre-selected product.
Blood tests are not routinely required to identify menopause in many women over 45, but may be clinically useful in younger women, suspected POI, unusual symptoms, differential diagnosis or before and during selected treatments.
Book a menopause consultationTreatment is matched to symptoms, health history and preference
Menopause care is more than a yes-or-no decision about HRT. A plan may include systemic or local hormonal treatment, non-hormonal medication, menopause-specific psychological support, lifestyle measures, contraception planning or referral.
Any prescription is considered by an appropriately authorised clinician after assessment. The route, dose, expected benefit, uncertainty, alternatives and monitoring are discussed individually.
HRT discussion
Hormone replacement therapy may be discussed for troublesome menopausal symptoms where the expected benefits are likely to outweigh the risks. The consultation considers whether oestrogen alone or oestrogen with endometrial protection is needed, and whether a patch, gel, spray, tablet or another route is appropriate.
Regulated medicines
We distinguish licensed regulated body-identical medicines from compounded preparations that do not follow the same UK medicines-authorisation pathway.
Vaginal oestrogen and local symptom support
Vaginal dryness, burning, painful intimacy, urgency and recurrent UTI-like symptoms may be part of GSM. Local vaginal oestrogen, moisturisers, lubricants or other local options may be discussed according to symptoms, medical history and preference.
Condition-specific handoff
Where intimate symptoms are the main concern, the dedicated GSM pathway may be more appropriate.
Non-hormonal options
Women who cannot use HRT, prefer not to use it or want to compare alternatives may discuss evidence-based non-hormonal approaches. The most appropriate choice depends on the symptom being treated, medical history, interactions and availability.
Examples discussed by suitability
Menopause-specific CBT, sleep and lifestyle support, and selected non-hormonal medicines for vasomotor symptoms may be considered where appropriate.
Testosterone assessment
Testosterone is not a general treatment for tiredness, weight, low mood or brain fog. It may be considered for selected women with persistent low sexual desire after other contributing factors and standard menopause care have been reviewed.
Monitoring is required
Baseline and follow-up blood testing, symptom review and avoidance of excessive levels form part of safe prescribing where treatment is used.
Lifestyle, sleep and psychological support
Sleep patterns, alcohol, smoking, movement, nutrition, workplace pressures and emotional wellbeing can affect symptoms and long-term health. These measures may be used alone or alongside medical treatment.
Support is symptom-led
Menopause-specific CBT may help some women with vasomotor symptoms, sleep or coping. Broader therapy may be useful when anxiety, confidence or relationship impact is prominent.
Contraception, early menopause and specialist referral
Perimenopause does not automatically mean contraception is no longer needed. Mirena use, HRT endometrial protection, fertility questions, early menopause, POI and surgical menopause may need tailored planning.
Referral when needed
Complex bleeding, cancer history, significant treatment risk, persistent symptoms or needs outside WHC’s scope may require GP, gynaecology, oncology or specialist menopause input.
Service scope
What WHC provides, coordinates or refers
Provided within scope
Menopause assessment, treatment planning, suitable private prescribing and clinical follow-up by the appropriate practitioner.
Discussed or coordinated
Blood tests, pharmacy arrangements, contraception overlap, intimate-health care and shared-care information where relevant.
Referred when appropriate
Urgent bleeding, complex cancer history, specialist gynaecology, cardiology, mental-health crisis or other needs outside service scope.
Suitability, risks and alternatives
Treatment decisions are category-specific
There is no single contraindication list that applies equally to every menopause treatment. The clinician assesses the risks of the particular option being considered and explains safer alternatives where necessary.
Investigate first
Bleeding and new symptoms
Postmenopausal bleeding, unexplained bleeding, a new breast or pelvic symptom, persistent urinary symptoms or suspected infection should be assessed before routine menopause treatment decisions are made.
Urgency depends on the symptom. The clinic will advise whether GP, urgent care, gynaecology or another route is appropriate.
Individual risk review
Systemic HRT suitability
Age, time since menopause, uterus status, bleeding, breast-cancer history, clotting history, migraine, liver disease and cardiovascular factors can affect whether systemic HRT is appropriate and which route is preferable.
A history that makes one route unsuitable does not automatically rule out all menopause support.
Oncology-aware care
Cancer history and local treatment
Hormone-sensitive cancer history requires careful review. Systemic HRT is usually not approached as routine care after breast cancer, while local vaginal treatment decisions may involve the oncology or specialist team depending on symptoms and treatment history.
Non-hormonal symptom support and dedicated GSM assessment remain available discussion routes.
Treatment-specific checks
Testosterone and non-hormonal medicines
Testosterone requires a narrow indication and blood monitoring. Non-hormonal medicines have their own contraindications, interactions and monitoring needs, so they are not automatically safer for every woman.
The clinician explains what the option is intended to treat and what outcome would trigger continuation, adjustment or stopping.
Monitoring, prescriptions and ongoing review
Menopause care continues after the first prescription
Where medication is started or changed, the plan should include an early review, commonly around three months, followed by at least annual review once treatment is established. More frequent review may be needed for symptoms, side effects or clinical risk.
Private prescription arrangements, pharmacy supply, blood tests and follow-up fees are confirmed before they are incurred.
Early treatment review
Check symptom response, side effects, bleeding pattern, adherence and whether dose or route needs changing.
Ongoing review
Revisit benefits, risks, blood pressure or relevant health checks, screening and continued treatment preference.
Prescription process
An authorised clinician issues or arranges the prescription where treatment is suitable; medicine and dispensing charges may be separate.
Escalation or referral
Unexpected bleeding, poor response, complex risk or needs outside scope may require testing, GP liaison or specialist referral.
Clinical review
Reviewed for menopause-service accuracy
Clinical reviewer: Dr Farzana, Women’s Health Doctor
Last reviewed: July 2026. Sources include current NICE menopause guidance, British Menopause Society clinical resources and RCOG patient guidance.
Consultation pathway and fees
Private menopause consultation pricing
Consultation pricing starts with a paid first-step route or a full menopause assessment according to the pathway advised.
Medication, dispensing, blood tests, repeat prescriptions, follow-up appointments and additional services may be separate. Current costs are confirmed before booking.
First-step route
Nurse consultation
A first conversation to understand your concerns, explain the service and help route you to the appropriate next appointment.
£50
Not a full menopause assessment.
Medical first-step route
Doctor telephone consultation
A doctor-led telephone consultation where a medical discussion is preferred or clinically advised before the full pathway.
£150
Scope and next step confirmed before booking.
Full initial assessment
Menopause consultation
An in-depth consultation covering symptoms, history, suitability, options, shared decision-making and the review plan.
£175 / £250
Nurse-led £175 · Doctor-led £250.
What may cost extra
Follow-up consultations
Review timing and fee depend on the treatment plan and practitioner.
Prescriptions and medicines
Prescription administration, dispensing and medicine charges may be separate.
Blood tests
Only requested when clinically useful; the cost is confirmed before testing.
Other services
Contraception, intimate-health treatment or external specialist care is priced separately.
Before booking
Choose the appointment that matches the help you need
The £50 nurse consultation is a first-step route. The £150 doctor telephone consultation is a medical first-step option. A full initial menopause assessment is £175 nurse-led or £250 doctor-led.
The team will confirm the route, format, clinician, location or video availability and any additional expected costs before the appointment is booked.
Clinician-led and joined-up
Private menopause care delivered with time, clarity and choice
Menopause can affect physical health, emotional wellbeing, sexual comfort, bladder symptoms, contraception and long-term planning. The service is structured to consider these areas together while respecting clinical boundaries.
National and video access
Telephone or video routes may be available where suitable. The format depends on symptoms, clinical need and practitioner availability.
In-clinic assessment
A face-to-face consultation may be advised for examination, bleeding, intimate symptoms, coil questions or complex history.
Appropriate practitioner
The team explains whether a nurse-led or doctor-led pathway is appropriate before you commit to the full consultation.
Local clinic handoff
Use the clinic directory for location-specific appointment information rather than relying on national-page assumptions.
Reviews
Experiences shared by women using WHC services
Women often value being able to talk openly, understand the plan and feel supported rather than rushed.
3,500+ reviews · 4.8/5 average rating
★★★★★
Kim Egmore
Verified Google review
★★★★★
Fantastic service by everyone. I could talk openly without feeling embarrassed, and everything was explained clearly. The team made me feel so comfortable and at ease.
sandygirl
Verified Google review
★★★★★
Finally, a place that explains everything fully. The staff put my mind at ease and I felt listened to, understood, and given sound advice.
Skye Mina
Verified Google review
★★★★★
Katy went above and beyond making me feel comfortable and making sure I understood everything that was happening and what to expect. Very nice and clean facilities.
One clear journey
From uncertainty to an ongoing menopause plan
The exact route varies, but the service should always make the next step, cost and clinical responsibility clear.
Notice a change
Symptoms affect sleep, mood, periods, cognition, intimacy or daily confidence.
Choose a first consultation
Nurse £50 or doctor telephone £150, according to the route preferred or advised.
Complete the assessment
A full nurse-led £175 or doctor-led £250 consultation reviews symptoms, risk and goals.
Agree the plan
Education, treatment, prescription, tests, condition pathway or referral are agreed together.
Review and adjust
Symptoms, side effects, risk and continued preference are reviewed over time.
Watch women’s health stories and clinic features
These videos reflect wider WHC experiences and education. They do not guarantee a particular menopause outcome, and individual care varies.
Questions to resolve before booking or starting treatment
These answers cover the residual questions that remain after the main service, assessment, treatment, safety, pricing and monitoring sections.
What is the difference between perimenopause and menopause?
Do I need a blood test to diagnose menopause?
Can WHC prescribe HRT?
What is regulated body-identical HRT?
Is HRT safe?
What non-hormonal treatments can be discussed?
Can menopause cause vaginal or urinary symptoms?
Can I discuss testosterone?
Do you help with early menopause, POI or surgical menopause?
Do I still need contraception during perimenopause?
Can I have a video menopause consultation?
What happens after treatment is started?
How much does the menopause service cost?
What if I have a history of breast cancer or blood clots?
What symptoms should not be ignored?
Can I stop at advice without starting treatment?
Your next step
Choose a paid consultation route
Start with the £50 nurse consultation, the £150 doctor telephone consultation, or book a full menopause assessment where the appropriate route has already been identified.
Clinical evidence sources
Guidance supporting this page
The content is governed by national menopause guidance and specialist professional resources, alongside WHC’s verified service scope and pricing.
NICE NG23 — Menopause: identification and management
National recommendations covering diagnosis, information, treatment choices, risks, POI and review.
View NICE guidanceNICE QS143 — Reviewing treatments for menopause-associated symptoms
Quality standard supporting early treatment review and at least annual review thereafter.
View review standardBritish Menopause Society
Professional resources on HRT, testosterone, GSM, early menopause, cancer context and regulated hormone terminology.
View BMS clinical toolsRoyal College of Obstetricians and Gynaecologists
Patient information on menopause symptoms, HRT and non-hormonal treatment choices.
View RCOG informationEducational only. This page does not replace personal medical assessment, diagnosis, prescribing advice, emergency care or specialist referral.
Continue learning about women’s health
Explore clinical articles covering menopause, intimate health, gynaecology and preventative care.
NuV Intimate Laser Rejuvenation Femilift MonalisaTouch Alternative
Restore Your Confidence & Intimate Wellness Professional Nu-V vaginal rejuvenation treatment by experienced nurses who understand your needs…
Read MoreFemale Sexual Function Index (FSFI)
Changing the lives of womenVirtual Consultations for Menopause, Sexual Health, Contraception, Diet, Nutrition, and moreUnderstanding the Female Sexual…
Read MoreOzempic (semaglutide) and vaginal health
Clinical report Evidence grading Integration guidelines Women’s health evidence review Ozempic (semaglutide) and vaginal health Comprehensive Clinical Report,…
Read MoreYour Guide to Polynucleotide Treatment for Intimate Wellness
Book Appointment Table of Contents What Exactly Are Polynucleotides? Safety Profile & Studies Indications: What Can It Help…
Read MoreStudy Guide: Understanding Pelvic Health and Sexual Comfort
Dr Farzana Khan qualified as an MD from the University of Copenhagen in 2003. She has worked in…
Read MoreBriefing on Pelvic Pain, Sexual Function, and Treatment Modalities
Dr Farzana Khan qualified as an MD from the University of Copenhagen in 2003. She has worked in…
Read More6 Surprising Truths About Sexual Health We Learned From a Top Women’s Clinic
Dr Farzana Khan qualified as an MD from the University of Copenhagen in 2003. She has worked in…
Read MoreSystemic HRT vs. Local Vaginal Estrogen: A Clear Guide to Your Menopause Treatment Options
Dr Farzana Khan qualified as an MD from the University of Copenhagen in 2003. She has worked in…
Read MoreUnderstanding Painful Sex: A Gentle Guide to Causes and Solutions
Dr Farzana Khan qualified as an MD from the University of Copenhagen in 2003. She has worked in…
Read MoreYour Guide to Vaginal Wellness Treatments: An Empowered Approach to Your Health
Dr Farzana Khan qualified as an MD from the University of Copenhagen in 2003. She has worked in…
Read MoreClinical Practice Guideline: Assessment and Management of Dyspareunia
Dr Farzana Khan qualified as an MD from the University of Copenhagen in 2003. She has worked in…
Read MorePainful Sex in Midlife (Dyspareunia): Causes, Assessment & Evidence-Based Support
Dr Farzana Khan qualified as an MD from the University of Copenhagen in 2003. She has worked in…
Read MoreVaginal Health and Support Study Guide
Vaginal Laxity Study Guide Dashboard Educational only. Not medical advice. Vaginal Health and Support Study Guide Short-Answer Quiz,…
Read MoreBriefing on Vaginal Laxity
Briefing on Vaginal Laxity: Causes, Assessment, and Treatment Pathways Educational only. Not medical advice. Briefing on Vaginal Laxity…
Read MoreYour Guide to a Stronger, More Comfortable Pelvic Floor
Your Guide to a Stronger Pelvic Floor Your Guide to a Stronger, More Comfortable Pelvic Floor A simple…
Read MoreUnderstanding Vaginal Laxity
Understanding Vaginal Laxity Guide Understanding Vaginal Laxity A Guide to Post-Childbirth and Menopausal Changes. Educational only. Not medical…
Read MoreA Patient’s Guide to Managing Vaginal Laxity
Patient's Guide to Vaginal Laxity Management A Patient's Guide to Managing Vaginal Laxity Conservative Strategies for Comfort and…
Read MoreClinical Protocol: Assessment and Stepwise Management of Vaginal Laxity Symptoms
Vaginal Laxity Management Protocol Clinical Protocol: Assessment and Stepwise Management of Vaginal Laxity Symptoms Evidence-Based Framework for Healthcare…
Read MoreVaginal Laxity After Birth & Menopause: UK Guide
Dr Farzana Khan qualified as an MD from the University of Copenhagen in 2003. She has worked in…
Read MoreVaginal Dryness & Genitourinary Syndrome of Menopause (GSM): A UK Guide
Dr Farzana Khan qualified as an MD from the University of Copenhagen in 2003. She has worked in…
Read MoreWorld Menopause Day 2025: Lifestyle Medicine and the Modern Menopause Journey
World Menopause Day 2025: Lifestyle Medicine and the Modern Menopause Journey Last reviewed: October 2025 #LifestyleMedicine #MenopauseAwareness #WomensHealth…
Read MoreYour Complete Guide to Building Mental Health Resilience – Womens Health and Menopause
Your Complete Guide to Building Mental Health Resilience Table of Contents What Actually Is Mental Health? The "I'm…
Read MoreFractional CO2 Laser Therapy in the Management of Pelvic Organ Prolapse: A Critical Review of Evidence, Mechanism, and Regulatory Status
Fractional CO2 Laser Therapy in the Management of Pelvic Organ Prolapse: A Critical Review of Evidence, Mechanism, and…
Read MoreFractional Carbon Dioxide (CO2) Laser Treatment Outcomes for Recurrent Urinary Tract Infection (rUTI)
Fractional Carbon Dioxide (CO2) Laser Treatment Outcomes for Recurrent Urinary Tract Infection (rUTI) Fractional Carbon Dioxide (CO2) Laser…
Read MoreVaginal Tightening Choices Vaginoplasty and Lasers LVR
This article from a UK gynecologist provides a comprehensive overview of vaginal tightening treatments, covering both surgical and…
Read MoreVAGINAL TIGHTENING: SURGICAL, NON SURGICAL, METHODS, BENEFITS, RISKS, AND CONSIDERATIONS
This article from a UK gynecologist provides a comprehensive overview of vaginal tightening treatments, covering both surgical and…
Read MoreWhat is Laser Vaginal Rejuvenation
In this comprehensive article, UK gynecologist Joe Daniels delves into the world of laser vaginal rejuvenation, offering an…
Read MoreFDA warning – Vaginal Rejuvenation
The Women’s Health Clinic (TWHC) Statement on FDA’s “Vaginal Rejuvenation” Warning and Potential Health Risks Exploring the implications…
Read MoreStill not sure where to start?
Browse the wider treatment pages or book a free consultation.
Browse focused women’s health questions
Use the FAQ library for specific questions that sit outside this national menopause-service overview.
